Open Outbreak

Seasonal influenza

Also known as: flu, influenza A, influenza B, H3N2, H1N1pdm09

Seasonal influenza, or flu, is a respiratory infection caused mainly by influenza A and B viruses. It circulates worldwide. People spread it through infectious droplets when coughing or sneezing, and through contaminated hands. Symptoms usually start 1–4 days after infection and include sudden fever, cough, body aches, headache and tiredness. Most people recover within about a week, although coughing can last longer. Flu can also cause pneumonia, worsen existing illnesses and lead to hospitalization or death. Pregnant people, young children, older adults and people with certain medical conditions are at greater risk. WHO estimates around one billion cases each year, including 3–5 million severe illnesses and 290,000–650,000 respiratory deaths. These are annual burden estimates, not a case-fatality rate. Vaccines are available and remain an important preventive measure, even when circulating viruses have changed. Rest, fluids and symptom relief help most uncomplicated cases; severe illness and illness in high-risk people need medical assessment. Seasonal peaks vary by climate, and surveillance tracks changes in circulating viruses.

Key facts

TransmissionPerson-to-person spread through infectious droplets dispersed by coughing or sneezing, especially nearby; contaminated hands can also spread the virus.
Incubation1–4 days, usually about 2 days.
Case fatalityUnknown from the retrieved sources; no reliable treated-versus-untreated case-fatality estimate was provided. WHO estimates 290,000–650,000 respiratory deaths annually worldwide.
Reproduction numberUnknown from the retrieved text. A 2014 systematic review examined reproduction-number estimates, but its numerical results were not accessible.
VaccineAvailable. WHO describes vaccination as the best way to prevent influenza; protection can persist despite differences between vaccine strains and circulating viruses.
TreatmentRest, fluids and symptom relief for uncomplicated illness. Severe symptoms or risk factors warrant medical care. The retrieved literature discusses antiviral medicines, but did not provide enough accessible detail for current drug-specific recommendations.
ReservoirPeople sustain circulation of seasonal influenza A and B viruses.
Endemic regionsWorldwide. Epidemics occur mainly in winter in temperate climates; tropical regions can have year-round circulation and irregular outbreaks.

Transmission

Seasonal flu spreads readily between people. WHO describes infectious droplets released when someone coughs or sneezes, which can infect people nearby. Hands contaminated with influenza viruses can also spread infection. Crowded settings, including schools and nursing homes, allow rapid transmission. The time between infection and symptoms is usually about two days, with a range of 1–4 days. Covering coughs and sneezes with a tissue and washing hands regularly are recommended precautions. Symptoms alone do not reliably identify flu: several other respiratory viruses can cause a similar illness. Laboratory testing may be needed to confirm which virus is responsible.

Symptoms and severity

Flu often starts suddenly, with fever, a usually dry cough, headache, muscle or joint pain, sore throat, a runny nose and marked tiredness. Most people recover from fever and other symptoms within a week, but coughing can last two weeks or longer. Serious complications include pneumonia and sepsis, a dangerous response to infection. Flu can also worsen existing diseases. Pregnant people, children under five, older people and people with chronic illnesses or weakened immune systems face greater risks. WHO estimates 3–5 million severe illnesses and 290,000–650,000 respiratory deaths annually worldwide. These estimates describe the overall burden; they do not establish an individual's chance of dying.

Treatment and vaccines

Most uncomplicated flu improves with rest, plenty of fluids and treatment to relieve symptoms. People with severe symptoms or medical conditions that raise their risk should seek medical care. The retrieved literature discusses antiviral medicines, but the accessible material does not support a current drug-specific treatment recommendation here. Vaccination is an important preventive measure. In its 2025-12-10 notice, WHO reported that early estimates suggested vaccines still protected children and adults against hospital attendance despite changes in circulating H3N2 viruses. Protection against clinical illness that season remained uncertain. WHO emphasized vaccination for people at high risk and their caregivers, noting that differences between vaccine strains and circulating viruses do not necessarily remove protection against severe illness.

Where it occurs

Seasonal influenza occurs throughout the world. In temperate climates, epidemics happen mainly during winter. In tropical regions, flu can circulate throughout the year, with outbreaks at less predictable times. All age groups can become infected. Local seasons differ in timing, duration, size and severity, influenced by circulating viruses, population immunity and environmental conditions. WHO's 2025 global notice described sustained tropical activity and unusually long seasons in some southern hemisphere countries. Its surveillance network monitors viruses year-round across many countries. Local surveillance is therefore more useful for judging present risk than assuming that flu follows the same calendar everywhere.

Recent history

Open Outbreak's supplied archive contains 14 influenza-related events, spanning 1996–2025. This is a count of selected notices and historical records, not every flu season or outbreak; some entries concern unusual influenza viruses rather than routine seasonal flu. On 2025-12-10, WHO reported rising global seasonal activity, with H3N2 predominating and a rapid increase in subclade K, a genetically distinct group within H3N2. Activity remained within expected global seasonal ranges, although some regions had early or unusually high activity. Available data did not indicate increased severity from subclade K. This is the latest seasonal-specific WHO notice retrieved for this page, not a verified assessment of conditions on 2026-11-15.

What to watch

Important signals include unusually early or prolonged seasons, rising severe illness or hospital attendance, and pressure on clinics and hospitals. Genetic changes matter most when accompanied by evidence of altered severity, spread or reduced vaccine protection; a new genetic label alone does not establish greater danger. Because seasonal flu already spreads between people worldwide, human-to-human transmission or detection in another country is not itself unusual. More concerning would be sustained spread of a novel influenza virus, or activity outside a region's usual seasonal pattern. Reduced antiviral effectiveness, vaccine supply problems and lower protection against severe disease also warrant attention. The retrieved sources do not establish current resistance or vaccine shortages.

Updated